{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,8,5]],"date-time":"2024-08-05T20:13:27Z","timestamp":1722888807746},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2006,3,21]],"date-time":"2006-03-21T00:00:00Z","timestamp":1142899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2006,3,21]],"date-time":"2006-03-21T00:00:00Z","timestamp":1142899200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Hematol"],"published-print":{"date-parts":[[2006,6]]},"DOI":"10.1007\/s00277-005-0073-1","type":"journal-article","created":{"date-parts":[[2006,3,20]],"date-time":"2006-03-20T09:44:16Z","timestamp":1142847856000},"page":"400-406","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":35,"title":["Rituximab in the management of chronic immune thrombocytopenic purpura: an effective and safe therapeutic alternative in refractory patients"],"prefix":"10.1007","volume":"85","author":[{"name":"On behalf of the Multi-institutional Retrospective Spanish Study on the use of rituximab in refractory ITP","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francisco Javier","family":"Pe\u00f1alver","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Victor","family":"Jim\u00e9nez-Yuste","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manuel","family":"Almagro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alberto","family":"Alvarez-Larr\u00e1n","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lluis","family":"Rodr\u00edguez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marisol","family":"Casado","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laura","family":"Gallur","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pilar","family":"Giraldo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roberto","family":"Hern\u00e1ndez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dolores","family":"Menor","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria Jos\u00e9","family":"Rodr\u00edguez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dolores","family":"Caballero","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ra\u00fal","family":"Gonz\u00e1lez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jos\u00e9","family":"Mayans","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Isabel","family":"Mill\u00e1n","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jos\u00e9 Rafael","family":"Cabrera","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2006,3,21]]},"reference":[{"key":"73_CR1","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1067\/S0022-3476(03)00446-3","volume":"143","author":"KL Bengston","year":"2003","unstructured":"Bengston KL, Skinner MA, Ware RE (2003) Successful use of anti-CD20 (Rituximab) in severe, life-threatening childhood immune thrombocytopenic purpura. J Pediatr 143:670\u2013673","journal-title":"J Pediatr"},{"key":"73_CR2","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1046\/j.1365-2141.2003.04131.x","volume":"120","author":"British Commitee for Standards in Haematology","year":"2003","unstructured":"British Commitee for Standards in Haematology (2003) Guidelines for the investigation and management of idiopathic thrombocytopenic purpura in adults, children and in pregnancy. Br J Haematol 120:574\u2013596","journal-title":"Br J Haematol"},{"key":"73_CR3","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1016\/S0037-1963(00)90104-5","volume":"37","author":"JB Bussel","year":"2000","unstructured":"Bussel JB (2000) Fc receptor blockade and immune thrombocytopenic purpura. Semin Hematol 37:261\u2013266","journal-title":"Semin Hematol"},{"key":"73_CR4","doi-asserted-by":"publisher","first-page":"995","DOI":"10.1056\/NEJMra010501","volume":"346","author":"DB Cines","year":"2002","unstructured":"Cines DB, Blanchette VS (2002) Immune thrombocytopenic purpura. N Engl J Med 346:995\u20131008","journal-title":"N Engl J Med"},{"key":"73_CR5","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1038\/sj.thj.6200148","volume":"3","author":"Y Cohen","year":"2002","unstructured":"Cohen Y, Polliack A (2002) Sustained complete remission of chronic refractory immune thrombocytopenic purpura (ITP) of 10\u00a0years duration after only two infusions of rituximab. Hematol J 3:61\u201362","journal-title":"Hematol J"},{"key":"73_CR6","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1111\/j.1365-2141.2004.04889.x","volume":"125","author":"N Cooper","year":"2004","unstructured":"Cooper N, Stasi R, Cunningham-Rundles S, Feuerstein MA, Leonard JP, Amadori S, Bussel JB (2004) The efficacy and safety of B-cell depletion with anti-CD20 monoclonal antibody in adults with chronic immune thrombocytopenic purpura. Br J Haematol 125:232\u2013239","journal-title":"Br J Haematol"},{"key":"73_CR7","doi-asserted-by":"publisher","first-page":"2623","DOI":"10.1182\/blood-2004-03-1168","volume":"104","author":"K Kajouri","year":"2004","unstructured":"Kajouri K, Vesely SK, Terrell DR, George JN (2004) Splenectomy for adults patients with idiopathic thrombocytopenic purpura: a systematic review to assess long-term platelet count response, prediction of response, and surgical complications. Blood 104:2623\u20132634","journal-title":"Blood"},{"key":"73_CR8","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1007\/s00277-002-0461-8","volume":"81","author":"S Kumar","year":"2002","unstructured":"Kumar S, Diehn FE, Gertz MA, Tefferi A (2002) Splenectomy for immune thrombocytopenic purpura: long-term results and treatment of postsplenectomy relapses. Ann Hematol 81:312\u2013319","journal-title":"Ann Hematol"},{"key":"73_CR9","doi-asserted-by":"crossref","first-page":"2188","DOI":"10.1182\/blood.V90.6.2188","volume":"90","author":"DG Maloney","year":"1997","unstructured":"Maloney DG, Grillo-L\u00f3pez AJ, White CA, Bodkin D, Schilder RJ, Neidhart JA, Janakiraman N, Foon KA, Liles TM, Dallaire BK, Wey K, Royston I, Davis T, Levy R (1997) IDEC-C2B8 (rituximab) anti-CD20 monoclonal antibody therapy in patients with relapsed low-grade non-Hodgkin's lymphoma. Blood 90:2188\u20132195","journal-title":"Blood"},{"key":"73_CR10","doi-asserted-by":"publisher","first-page":"2549","DOI":"10.1182\/blood.V97.9.2549","volume":"97","author":"JEA Portielje","year":"2001","unstructured":"Portielje JEA, Westendorp RGJ, Kluin-Nelemans HC, Brand A (2001) Morbidity and mortality in adults with idiopathic thrombocytopenic purpura. Blood 97:2549\u20132554","journal-title":"Blood"},{"key":"73_CR11","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1182\/blood.V83.2.435.435","volume":"83","author":"ME Reff","year":"1994","unstructured":"Reff ME, Carner K, Chambers KS, Chinn PC, Leonard JE, Raab R, Newman RA, Hanna N, Anderson DR (1994) Depletion of B cells in vivo by a chimeric mouse human monoclonal antibody to CD20. Blood 83:435\u2013445","journal-title":"Blood"},{"key":"73_CR12","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1002\/ajh.10253","volume":"72","author":"J Schwartz","year":"2003","unstructured":"Schwartz J, Leber MD, Gillis S, Giunta A, Eldor A, Bussel JB (2003) Long-term follow-up after splenectomy performed for immune thrombocytopenic purpura (ITP). Am J Hematol 72:94\u201398","journal-title":"Am J Hematol"},{"key":"73_CR13","doi-asserted-by":"publisher","first-page":"1340","DOI":"10.4065\/78.11.1340","volume":"78","author":"TD Shanafelt","year":"2003","unstructured":"Shanafelt TD, Madume HL, Wolf RC, Tefferi A (2003) Rituximab for immune cytopenia in adults: idiopathic thrombocytopenic purpura, autoimmune haemolytic anemia, and Evans syndrome. Mayo Clin Proc 78:1340\u20131346","journal-title":"Mayo Clin Proc"},{"key":"73_CR14","doi-asserted-by":"publisher","first-page":"952","DOI":"10.1182\/blood.V98.4.952","volume":"98","author":"R Stasi","year":"2001","unstructured":"Stasi R, Pagano A, Stipa E, Amadori S (2001) Rituximab chimeric anti-CD20 monoclonal antibody treatment for adults with chronic idiopathic thrombocytopenic purpura. Blood 98:952\u2013957","journal-title":"Blood"},{"key":"73_CR15","doi-asserted-by":"crossref","first-page":"504","DOI":"10.4065\/79.4.504","volume":"79","author":"R Stasi","year":"2004","unstructured":"Stasi R, Provan D (2004) Management of immune thrombocytopenic purpura in adults. Mayo Clin Proc 79:504\u2013522","journal-title":"Mayo Clin Proc"},{"key":"73_CR16","first-page":"281","volume":"90","author":"T Taube","year":"2005","unstructured":"Taube T, Schmid H, Reinhard H, von Stackelberg A, Henze G, Overberg US (2005) Effect of a single dose of rituximab in chronic immune thrombocytopenic purpura in childhood. Haematologica 90:281\u2013283","journal-title":"Haematologica"},{"key":"73_CR17","first-page":"72","volume":"90","author":"N Vianelli","year":"2005","unstructured":"Vianelli N, Galli M, de Vivo A, Intermesoli T, Giannini B, Mazzuconi MG, Barbui T, Tura S, Baccarini M (2005) Efficacy and safety of splenectomy in immune thrombocytopenic purpura: long-term results of 402 cases. Haematologica 90:72\u201377","journal-title":"Haematologica"},{"key":"73_CR18","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1016\/j.biopha.2004.04.006","volume":"58","author":"L Virgolini","year":"2004","unstructured":"Virgolini L, Marzocchi V (2004) Rituximab in autoimmune diseases. Biomed Pharmacother 58:299\u2013309","journal-title":"Biomed Pharmacother"},{"key":"73_CR19","first-page":"1634a","volume":"53","author":"J Wang","year":"2003","unstructured":"Wang J, Feuerstein M, Bussel JB (2003) Rituximab treatment for pediatric patients with chronic immune thrombocytopenic purpura (ITP) (abstract). Pediatr Res 53:1634a","journal-title":"Pediatr Res"},{"key":"73_CR20","first-page":"189","volume":"87","author":"F Zaja","year":"2002","unstructured":"Zaja F, Iacona I, Masolini P, Russo D, Sperotto A, Prosdocimo S, Patriarca F, De Vita S, Regazzi M, Baccarini M, Fanin R (2002) B-cell depletion with rituximab as treatment for immune hemolytic anemia and thrombocytopenia. Haematologica 87:189\u2013195","journal-title":"Haematologica"},{"key":"73_CR21","doi-asserted-by":"publisher","first-page":"3857","DOI":"10.1182\/blood-2002-11-3547","volume":"101","author":"M Zecca","year":"2003","unstructured":"Zecca M, Nobili B, Ramenghi U, Perotta S, Amendola G, Rosito P et al (2003) Rituximab for the treatment of refractory autoimmune hemolytic anemia in children. Blood 101:3857\u20133861","journal-title":"Blood"}],"container-title":["Annals of Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-005-0073-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00277-005-0073-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-005-0073-1","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-005-0073-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,29]],"date-time":"2022-07-29T01:28:54Z","timestamp":1659058134000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00277-005-0073-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,3,21]]},"references-count":21,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2006,6]]}},"alternative-id":["73"],"URL":"https:\/\/doi.org\/10.1007\/s00277-005-0073-1","relation":{},"ISSN":["0939-5555","1432-0584"],"issn-type":[{"type":"print","value":"0939-5555"},{"type":"electronic","value":"1432-0584"}],"subject":[],"published":{"date-parts":[[2006,3,21]]},"assertion":[{"value":"30 November 2005","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 December 2005","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 March 2006","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}